“Test and treat” legislation at the state level is transforming pharmacists from dispensers into providers, authorizing them to diagnose and prescribe for conditions like flu, strep, and COVID-19 without physician oversight. As the map illustrates, this model is now active in more than 20 “direct open market” states (green), with legislation pending in key “battleground” states (yellow). JUCM first reported this disruption in 2015, and now the strategic intent is finally meeting regulatory reality.1 As …
Read More